These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 20078677)
1. Psychopathology in methamphetamine-dependent adults 3 years after treatment. Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson RA; Drug Alcohol Rev; 2010 Jan; 29(1):12-20. PubMed ID: 20078677 [TBL] [Abstract][Full Text] [Related]
2. Course of Psychiatric Symptoms and Abstinence among Methamphetamine-Dependent Persons in Sober Living Recovery Homes. Polcin DL; Witbrodt J; Korcha R; Gupta S; Mericle AA J Psychoactive Drugs; 2016; 48(3):173-80. PubMed ID: 27184803 [TBL] [Abstract][Full Text] [Related]
3. Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R; Am J Addict; 2010; 19(5):385-90. PubMed ID: 20716300 [TBL] [Abstract][Full Text] [Related]
4. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R; J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802 [TBL] [Abstract][Full Text] [Related]
5. Primary and substance-induced psychotic disorders in methamphetamine users. Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB Psychiatry Res; 2015 Mar; 226(1):91-6. PubMed ID: 25677394 [TBL] [Abstract][Full Text] [Related]
6. Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors. Akindipe T; Wilson D; Stein DJ Metab Brain Dis; 2014 Jun; 29(2):351-7. PubMed ID: 24532047 [TBL] [Abstract][Full Text] [Related]
7. The profile of psychiatric symptoms exacerbated by methamphetamine use. McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; McD Young R; Voce A; Saunders JB Drug Alcohol Depend; 2016 Apr; 161():104-9. PubMed ID: 26874915 [TBL] [Abstract][Full Text] [Related]
8. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. Shoptaw S; Peck J; Reback CJ; Rotheram-Fuller E J Psychoactive Drugs; 2003 May; 35 Suppl 1():161-8. PubMed ID: 12825759 [TBL] [Abstract][Full Text] [Related]
9. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. Glasner-Edwards S; Marinelli-Casey P; Hillhouse M; Ang A; Mooney LJ; Rawson R; J Nerv Ment Dis; 2009 Apr; 197(4):225-31. PubMed ID: 19363377 [TBL] [Abstract][Full Text] [Related]
10. Psychiatric comorbidity in methamphetamine dependence. Salo R; Flower K; Kielstein A; Leamon MH; Nordahl TE; Galloway GP Psychiatry Res; 2011 Apr; 186(2-3):356-61. PubMed ID: 21055832 [TBL] [Abstract][Full Text] [Related]
11. A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context. Vos PJ; Cloete KJ; le Roux A; Kidd M; Jordaan GP Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):390-4. PubMed ID: 21390410 [TBL] [Abstract][Full Text] [Related]
12. Profile of psychiatric symptoms in methamphetamine users in China: Greater risk of psychiatric symptoms with a longer duration of use. Ma J; Sun XJ; Wang RJ; Wang TY; Su MF; Liu MX; Li SX; Han Y; Meng SQ; Wu P; Shi J; Bao YP; Lu L Psychiatry Res; 2018 Apr; 262():184-192. PubMed ID: 29453037 [TBL] [Abstract][Full Text] [Related]
13. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Hoffman WF; Moore M; Templin R; McFarland B; Hitzemann RJ; Mitchell SH Psychopharmacology (Berl); 2006 Oct; 188(2):162-70. PubMed ID: 16915378 [TBL] [Abstract][Full Text] [Related]
14. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Weber E; Blackstone K; Iudicello JE; Morgan EE; Grant I; Moore DJ; Woods SP; Drug Alcohol Depend; 2012 Sep; 125(1-2):146-53. PubMed ID: 22560676 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Hasin D; Samet S; Nunes E; Meydan J; Matseoane K; Waxman R Am J Psychiatry; 2006 Apr; 163(4):689-96. PubMed ID: 16585445 [TBL] [Abstract][Full Text] [Related]
16. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand. Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802 [TBL] [Abstract][Full Text] [Related]
17. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. Iudicello JE; Woods SP; Vigil O; Scott JC; Cherner M; Heaton RK; Atkinson JH; Grant I; J Clin Exp Neuropsychol; 2010 Aug; 32(7):704-18. PubMed ID: 20198527 [TBL] [Abstract][Full Text] [Related]
18. Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders. Temmingh HS; van den Brink W; Howells F; Sibeko G; Stein DJ J Dual Diagn; 2020; 16(2):208-217. PubMed ID: 31984872 [No Abstract] [Full Text] [Related]
19. Methamphetamine use by incarcerated women: comorbid mood and anxiety problems. Vik PW Womens Health Issues; 2007; 17(4):256-63. PubMed ID: 17544297 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Kidorf M; Disney ER; King VL; Neufeld K; Beilenson PL; Brooner RK Drug Alcohol Depend; 2004 May; 74(2):115-22. PubMed ID: 15099655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]